{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:45:45Z","timestamp":1793573145071,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.preghy.2024.101153","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T05:54:58Z","timestamp":1725170098000},"page":"101153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Optimal treatment for women with acute hypertension in pregnancy; a randomized trial comparing intravenous labetalol versus nicardipine"],"prefix":"10.1016","volume":"38","author":[{"given":"Jeske M.","family":"bij de Weg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Y.","family":"Gravesteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wietske","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessel","family":"Ganzevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"van Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Willem Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne J.M.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.preghy.2024.101153_b0005","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.mayocp.2018.04.033","article-title":"State-of-the-art diagnosis and treatment of hypertension in pregnancy","volume":"93","author":"Magee","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.preghy.2024.101153_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.earlhumdev.2016.09.007","article-title":"Preeclampsia; short and long-term consequences for mother and neonate","volume":"102","author":"Bokslag","year":"2016","journal-title":"Early Hum Dev."},{"issue":"10022","key":"10.1016\/j.preghy.2024.101153_b0015","first-page":"999","volume":"387","author":"Mol","year":"2016","journal-title":"Pre-Eclampsia. Lancet."},{"key":"10.1016\/j.preghy.2024.101153_b0020","doi-asserted-by":"crossref","unstructured":"Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2013(7):CD001449.","DOI":"10.1002\/14651858.CD001449.pub3"},{"key":"10.1016\/j.preghy.2024.101153_b0025","unstructured":"NVOG richtlijn: Hypertensieve aandoeningen in de zwangerschap. 2018."},{"key":"10.1016\/j.preghy.2024.101153_b0030","unstructured":"Hypertension in Pregnancy: diagnosis and management. NICE 2023. https:\/\/www.nice.org.uk\/guidance\/ng133."},{"issue":"2","key":"10.1016\/j.preghy.2024.101153_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/healthcare10020325","article-title":"Antihypertensive Medications for Severe Hypertension in Pregnancy: A Systematic Review and Meta-Analysis","volume":"10","author":"Awaludin","year":"2022","journal-title":"Healthcare (basel)."},{"issue":"1","key":"10.1016\/j.preghy.2024.101153_b0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1471-0528.13463","article-title":"Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis","volume":"123","author":"Shekhar","year":"2016","journal-title":"BJOG."},{"issue":"5","key":"10.1016\/j.preghy.2024.101153_b0045","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/AOG.0b013e3182a9ea68","article-title":"Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial","volume":"122","author":"Shekhar","year":"2013","journal-title":"Obstet Gynecol."},{"issue":"9","key":"10.1016\/j.preghy.2024.101153_b0050","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00134-002-1406-3","article-title":"Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol","volume":"28","author":"Elatrous","year":"2002","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.preghy.2024.101153_b0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-0528.2011.03151.x","article-title":"Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial","volume":"119","author":"Raheem","year":"2012","journal-title":"BJOG."},{"issue":"4","key":"10.1016\/j.preghy.2024.101153_b0060","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-9378(99)70314-5","article-title":"A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy","volume":"181","author":"Vermillion","year":"1999","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2024.101153_b0065","article-title":"Antihypertensive Medications for Severe Hypertension in Pregnancy: A Systematic Review and Meta-Analysis","volume":"10","author":"Awaludin","year":"2022","journal-title":"Healthcare (basel)."},{"key":"10.1016\/j.preghy.2024.101153_b0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2014.10.111","article-title":"Oral nifedipine versus intravenous labetalol for the treatment of severe hypertension in pregnancy","volume":"178","author":"Shi","year":"2015","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.preghy.2024.101153_b0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2019.01.022","article-title":"IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial","volume":"236","author":"Zulfeen","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.preghy.2024.101153_b0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1389201015666140330194722","article-title":"The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine","volume":"15","author":"Nooij","year":"2014","journal-title":"Curr Pharm. Biotechnol."},{"issue":"4","key":"10.1016\/j.preghy.2024.101153_b0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1258\/om.2012.120010","article-title":"Oral nifedipine versus intravenous labetalol in hypertensive urgencies and emergencies of pregnancy: a randomized clinical trial","volume":"5","author":"Sathya Lakshmi","year":"2012","journal-title":"Obstet Med."},{"issue":"9","key":"10.1016\/j.preghy.2024.101153_b0090","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/aogs.14406","article-title":"Nicardipine for treating severe antepartum hypertension during pregnancy: Nine years of experience in more than 800 women","volume":"101","author":"Nij Bijvank","year":"2022","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"1","key":"10.1016\/j.preghy.2024.101153_b0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/uog.14836","article-title":"Hemodynamic effects of intravenous nicardipine in severely pre-eclamptic women with a hypertensive crisis","volume":"47","author":"Cornette","year":"2016","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2024.101153_b0100","doi-asserted-by":"crossref","first-page":"e20160731","DOI":"10.1542\/peds.2016-0731","article-title":"Late Pregnancy \u03b2 Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia","volume":"138","author":"Bateman","year":"2016","journal-title":"Pediatrics."},{"key":"10.1016\/j.preghy.2024.101153_b0105","doi-asserted-by":"crossref","unstructured":"Lisonkova, Bone, SN, Muraca, GM, Razaz, N, Wang, LQ, Sabr, Y, Boutin, A, Mayer, C, Joseph, KS. Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study. Am. J. Obstet. Gynecol. 2021 Nov;225(5):538.e1-538.e19.","DOI":"10.1016\/j.ajog.2021.04.261"},{"key":"10.1016\/j.preghy.2024.101153_b0110","doi-asserted-by":"crossref","unstructured":"Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, Carbonne B. Calciumchannelblockersforinhibitingpretermlabourandbirth. Cochrane Database Syst Rev. 2014 Jun 5;2014(6):CD002255.","DOI":"10.1002\/14651858.CD002255.pub2"},{"issue":"5","key":"10.1016\/j.preghy.2024.101153_b0115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.116.07862","article-title":"The CHIPS randomized controlled trial (Control of Hypertension in Pregnancy Study): is severe hypertension just an elevated blood pressure?","volume":"68","author":"Magee","year":"2016","journal-title":"Hypertension."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778924001806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778924001806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:30:03Z","timestamp":1740807003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778924001806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":23,"alternative-id":["S2210778924001806"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2024.101153","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal treatment for women with acute hypertension in pregnancy; a randomized trial comparing intravenous labetalol versus nicardipine","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2024.101153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101153"}}